| Symbol | SPPH |
|---|---|
| Name | SPENCER PHARMACEUTICAL INC. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | K1Z 5C7 Canada ON 413 Churchill Ave. North |
| Telephone | 613-808-0542 |
| Fax | — |
| — | |
| Website | http://www.spencerpharmaceuticalinternational.com |
| Incorporation | US |
| Incorporated On | 1998 |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | Laposta & Associates; |
| Audit Status | NOT AVAILABLE |
| Reporting Status | Dark: Alternative Reporting Standard |
| CIK | 0001143932 |
| Description | Spencer Pharmaceutical is a multi disciplinary company, which develops several patented drug platforms technologies for the treatment of Neurological diseases such as Alzheimer, Parkinson, and Multiple Scleroses as well as patented slow release drug delivery technology for the treatment of type-2 diabetes and arthritis Additional info from OTC: |
No news found.